NYON, Switzerland--(BUSINESS WIRE)--Mymetics Corporation (OTCBB: MYMX; http://www.mymetics.com), a biotechnology company focused on the development of protective mucosal antibody-based vaccines, hired the Investor Relations Group (“IRG”), a corporate communications firm based in New York City, to serve as its investor relations and financial public relations firm.
